These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3569868)

  • 21. Histocompatibility antigens in familial multiple sclerosis in a high-risk area of the disease.
    Kinnunen E; Koskimies S; Lagerstedt A; Wikström J
    J Neurol Sci; 1984 Aug; 65(2):147-55. PubMed ID: 6592288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple sclerosis in the Orkney and Shetland Islands. III: Histocompatibility determinants.
    Poskanzer DC; Terasaki PI; Prenney LB; Sheridan JL; Park MS
    J Epidemiol Community Health; 1980 Dec; 34(4):253-7. PubMed ID: 6972433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A meta-analysis of genomic screens in multiple sclerosis. The Transatlantic Multiple Sclerosis Genetics Cooperative.
    Mult Scler; 2001 Feb; 7(1):3-11. PubMed ID: 11321191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population.
    Marrosu MG; Cocco E; Costa G; Murru MR; Mancosu C; Murru R; Lai M; Sardu C; Contu P
    J Neurol; 2006 Feb; 253(2):208-13. PubMed ID: 16096810
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [HLA and multiple sclerosis. Studies of a spanish population].
    Uría DF
    Rev Neurol; 2000 Dec 1-15; 31(11):1066-70. PubMed ID: 11190875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Genes and multiple sclerosis].
    Tienari P; Palo J; Wikström J; Palotie L
    Duodecim; 1994; 110(7):741-8. PubMed ID: 8542829
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of negative and multiple HLA antigen disease associations.
    Thomson G; Nicholas FW; Bodmer WF; O'Neill ME; Hedrick PW; Hudes E
    Tissue Antigens; 1985 Nov; 26(5):293-306. PubMed ID: 3867175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunogenetic analysis of multiple sclerosis].
    Govaerts A
    Bull Mem Acad R Med Belg; 1983; 138(4):300-5. PubMed ID: 6640186
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetics and multiple sclerosis: an overview.
    Ebers GC
    Ann Neurol; 1994; 36 Suppl():S12-4. PubMed ID: 8017871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.
    Chao MJ; Barnardo MC; Lui GZ; Lincoln MR; Ramagopalan SV; Herrera BM; Dyment DA; Sadovnick AD; Ebers GC
    Hum Mol Genet; 2007 Aug; 16(16):1951-8. PubMed ID: 17584771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA antigens in multiple sclerosis of northern Spanish population.
    López-Larrea C; Uría DF; Coto E
    J Neurol Neurosurg Psychiatry; 1990 May; 53(5):434-5. PubMed ID: 2351974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of the HLA-G gene polymorphism with multiple sclerosis in a Polish population.
    Wiśniewski A; Bilińska M; Klimczak A; Wagner M; Majorczyk E; Nowak I; Pokryszko-Dragan A; Kuśnierczyk P
    Int J Immunogenet; 2010 Aug; 37(4):307-11. PubMed ID: 20636826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family and twin studies in multiple sclerosis.
    McFarland HF; Greenstein J; McFarlin DE; Eldridge R; Xu XH; Krebs H
    Ann N Y Acad Sci; 1984; 436():118-24. PubMed ID: 6398014
    [No Abstract]   [Full Text] [Related]  

  • 34. Multiple sclerosis: multiple etiologies, multiple genes?
    Tienari PJ
    Ann Med; 1994 Aug; 26(4):259-69. PubMed ID: 7524545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic susceptibility to multiple sclerosis: a linkage analysis with age-of-onset corrections.
    Haile RW; Hodge SE; Visscher BR; Spence MA; Detels R; McAuliffe TL; Park MS; Dudley JP
    Clin Genet; 1980 Sep; 18(3):160-7. PubMed ID: 7438496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis: a polygenic disease involving epistatic interactions, germline rearrangements and environmental effects.
    Karpuj MV; Steinman L; Oksenberg JR
    Neurogenetics; 1997 May; 1(1):21-8. PubMed ID: 10735270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.
    Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J
    PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Power of the affected-sib-pair method to defect disease susceptibility loci of small effect: an application to multiple sclerosis.
    Suarez B; O'Rourke D; Van Eerdewegh P
    Am J Med Genet; 1982 Jul; 12(3):309-26. PubMed ID: 6956238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A follow-up study of Nordic multiple sclerosis candidate gene regions.
    Datta P; Harbo HF; Ryder LP; Akesson E; Benedikz J; Celius EG; Andersen O; Myhr KM; Sandberg-Wollheim M; Hillert J; Svejgaard A; Sorensen PS; Spurkland A; Oturai A
    Mult Scler; 2007 Jun; 13(5):584-9. PubMed ID: 17548436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The affected sib method. II. The intermediate model.
    Louis EJ; Thomson G; Payami H
    Ann Hum Genet; 1983 Jul; 47(3):225-43. PubMed ID: 6688509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.